Walleye Capital’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-17,166
| Closed | -$36.9K | – | 2126 |
|
2025
Q1 | $36.9K | Buy |
+17,166
| New | +$36.9K | ﹤0.01% | 1659 |
|
2024
Q3 | – | Sell |
-10,939
| Closed | -$79.3K | – | 2701 |
|
2024
Q2 | $79.3K | Sell |
10,939
-30,110
| -73% | -$218K | ﹤0.01% | 2100 |
|
2024
Q1 | $312K | Sell |
41,049
-17,501
| -30% | -$133K | ﹤0.01% | 1624 |
|
2023
Q4 | $266K | Sell |
58,550
-148,333
| -72% | -$675K | ﹤0.01% | 1390 |
|
2023
Q3 | $817K | Buy |
206,883
+15,154
| +8% | +$59.9K | ﹤0.01% | 967 |
|
2023
Q2 | $600K | Buy |
+191,729
| New | +$600K | ﹤0.01% | 934 |
|